Peter L Hsu

7PUBLICATIONS
36CO-AUTHORS
Biologically active moleculesMolecular targetsCheminformatics and quantitative structure-activity relationshipsReaction engineering (excl. nuclear reactions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model.

|Jun 17, 2026
Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State Inhibitors.

|Jun 17, 2026
Optimization Leading to a Potent and Selective Cbl‑b Inactive-State Inhibitor That Demonstrated <i>In Vivo</i> Efficacy.

|Apr 15, 2026
Template-driven scaffolding of SCF<sup>FBXO42</sup> regulates PP2A degradation.

|Dec 11, 2025
Chemically-induced degradation of the endoplasmic-reticulum stress sensor IRE1 by a VHL-recruiting chimera.

Jin Du, Elisia Villemure, Matthew Johnson

|Feb 18, 2025
Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition.

Sayantanee Paul, Thijs J Hagenbeek, Julien Tremblay

Pageof 2

Frequent Collaborators

2 joint publications

Michael J Lambrecht

2 joint publications

Jun Liang

2 joint publications

Peter Man-Un Ung

2 joint publications

Georgette M Castanedo